Comparison of bone formation responses to parathyroid hormone(1-34), (1-31), and (2-34) in mice

被引:91
作者
Mohan, S
Kutilek, S
Zhang, C
Shen, HG
Kodama, Y
Srivastava, AK
Wergedal, JE
Beamer, WG
Baylink, DJ
机构
[1] Loma Linda Univ, Jerry L Pettis Mem Vet Adm Med Ctr, Musculoskeletal Dis Ctr 151, Loma Linda, CA 92357 USA
[2] Jackson Lab, Bar Harbor, ME 04609 USA
关键词
bone formation; bone resorption; bone strength; osteoblasts; parathyroid hormone (PTH) analogs; PTH signaling;
D O I
10.1016/S8756-3282(00)00355-0
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
In this study we used a mouse model system to compare the in vivo effects of parathyroid hormone(1-34) [PTH(1-34)] with that of PTH(1-31) or PTH(2-34) analogs. Daily subcutaneous administration of PTH(1-34) for 15 days caused a dose-dependent increase in the serum osteocalcin level and bone extract alkaline phosphatase activity, markers of bone formation. PTH(2-34) was much less potent, whereas PTH(1-31) was equipotent in stimulating bone formation parameters in mice. PTH(1-34) caused significant increases in serum calcium (after 4 h) and tartrate-resistant acid phosphatase activity in bone extract (after 4 h), whereas PTH(2-34) and PTH(1-31) were less potent. Because PTH(1-31) caused a smaller increase in bone resorption parameters compared to PTH(1-34), despite similar effects on bone formation parameters, we evaluated the long-term anabolic effects of PTH(1-31) and PTH(1-34) in mice. Weekly evaluations of serum osteocalcin levels demonstrated that daily injections of PTH(1-34) and PTH(1-31) at 80 mu g/kg body weight increased serum osteocalcin levels within 1 week of the start of treatment, which were maintained during the entire 22 week treatment. Assessment of bone density at the end of the treatment period with peripheral quantitated computed tomography (pQCT) revealed that PTH(1-34) caused a significantly greater increase in femoral bone density compared to PTH(1-31) at the middiaphysis (18% vs. 9% over vehicle control; p < 0.001). Both PTH(1-34) and PTH(1-31) increased periosteal circumference compared to vehicle (p < 0.01) without a significant difference between the two treatments. In contrast, PTH(1-34) caused a significantly greater reduction in endosteal circumference than PTH(1-31) (p < 0.001). Both analogs significantly increased maximum load and area of moment of inertia over the vehicle group. In conclusion, our findings suggest that PTH(1-34) and PTH(1-31) may exhibit different anabolic effects at the periosteum vs. endosteum in the long bones of mice, (Bone 27:471-478; 2000) (C) 2000 by Elsevier Science Inc. All rights reserved.
引用
收藏
页码:471 / 478
页数:8
相关论文
共 52 条
  • [1] An intact N terminus is required for the anabolic action of parathyroid hormone on adult female rats
    ArmamentoVillareal, R
    Ziambaras, K
    AbbasiJarhomi, SH
    Dimarogonas, A
    Halstead, L
    Fausto, A
    Avioli, LV
    Civitelli, R
    [J]. JOURNAL OF BONE AND MINERAL RESEARCH, 1997, 12 (03) : 384 - 392
  • [2] The diagnosis and treatment of osteoporosis: future prospects
    Baylink, DJ
    Strong, DD
    Mohan, S
    [J]. MOLECULAR MEDICINE TODAY, 1999, 5 (03): : 133 - 140
  • [3] Genetic variability in adult bone density among inbred strains of mice
    Beamer, WG
    Donahue, LR
    Rosen, CJ
    Baylink, DJ
    [J]. BONE, 1996, 18 (05) : 397 - 403
  • [4] CHAPOTEAU E, 1993, CLIN CHEM, V39, P1820
  • [5] COLE JA, 1989, J BONE MINER RES, V4, P723
  • [6] Skeletal response to dietary zinc in adult female mice
    Dimai, HP
    Hall, SL
    Stilt-Coffing, B
    Farley, JR
    [J]. CALCIFIED TISSUE INTERNATIONAL, 1998, 62 (04) : 309 - 315
  • [7] The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats
    Dobnig, H
    Turner, RT
    [J]. ENDOCRINOLOGY, 1997, 138 (11) : 4607 - 4612
  • [8] HUMAN PARATHYROID HORMONE(1-34) INCREASES BONE-FORMATION AND STRENGTH OF CORTICAL BONE IN AGED RATS
    EJERSTED, C
    ANDREASSEN, TT
    NILSSON, MHL
    OXLUND, H
    [J]. EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1994, 130 (02) : 201 - 207
  • [9] Evans DB, 1996, J BONE MINER RES, V11, P1066
  • [10] Comparison of the biochemical responses to human parathyroid hormone-(1-31)NH2 and hPTH-(1-34) in healthy humans
    Fraher, LJ
    Avram, R
    Watson, PH
    Hendy, GN
    Henderson, JE
    Chong, KL
    Goltzman, D
    Morley, P
    Willick, GE
    Whitfield, JF
    Hodsman, AB
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1999, 84 (08) : 2739 - 2743